Infinity Announces Conference Call Discussing R&D Progress and First Quarter 2008 Results


CAMBRIDGE, Mass., April 28, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management will host a conference call on Monday, May 5, 2008 at 4:30 p.m. EDT. In the conference call, management will provide a research and development update and discuss results for the quarter ended March 31, 2008.

To participate in the conference call, please dial 1-800-634-6308 (domestic) and 1-719-325-4873 (international) five minutes prior to the start time. A live webcast of the conference call, including the presentation slides, can be accessed in the Investors/Media section of Infinity's website at www.infi.com. An archived version of the webcast will be available on Infinity's website for 30 days.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.infi.com.

INFI-G



            

Contact Data